121 related articles for article (PubMed ID: 30141520)
1. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data.
Wieser S; Schmidt M; Kind AB; Heinzelmann-Schwarz VA
Swiss Med Wkly; 2018 Jul; 148():w14647. PubMed ID: 30141520
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland.
Levi F; Franceschi S; La Vecchia C; Ruzicka J; Gloor E; Randimbison L
Ann Oncol; 1993 Apr; 4(4):289-94. PubMed ID: 8518218
[TBL] [Abstract][Full Text] [Related]
3. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
4. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
[TBL] [Abstract][Full Text] [Related]
5. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
Bristow RE; Palis BE; Chi DS; Cliby WA
Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study.
Zijlstra M; Timmermans M; Fransen H; van der Aa M; Reyners A; Raijmakers N; van de Poll-Franse L
Int J Gynecol Cancer; 2019 Jul; 29(6):1032-1037. PubMed ID: 31263022
[TBL] [Abstract][Full Text] [Related]
8. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013.
Andres M; Feller A; Arndt V;
Cancer Epidemiol; 2018 Apr; 53():105-110. PubMed ID: 29414629
[TBL] [Abstract][Full Text] [Related]
9. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
[TBL] [Abstract][Full Text] [Related]
10. Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.
Feller A; Bopp M; Lorez M; Zellweger U; Adam M; Curjuric I; Staehelin K; Perren A; Bergeron Y; Rapiti E; Mousavi M; Diebold J; Dyntar D; Bulliard JL; Maspoli Conconi M; Bordoni A; Konzelmann I; Wagner U; Rohrmann S
Swiss Med Wkly; 2020 Jan; 150():w20179. PubMed ID: 32031233
[No Abstract] [Full Text] [Related]
11. Reply to comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647.
Wieser S; Schmidt M; Kind AB; Heinzelmann-Schwarz VA
Swiss Med Wkly; 2020 Jan; 150():w20180. PubMed ID: 32031232
[No Abstract] [Full Text] [Related]
12. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
16. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
Schrag D; Earle C; Xu F; Panageas KS; Yabroff KR; Bristow RE; Trimble EL; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):163-71. PubMed ID: 16449676
[TBL] [Abstract][Full Text] [Related]
17. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract][Full Text] [Related]
18. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
Timmermans M; Schuurman MS; Ho VKY; Massuger LF; Nijman HW; van Gorp T; Sonke GS; Kruitwagen RFPM; van der Aa MA
Gynecol Oncol; 2018 Jan; 148(1):56-61. PubMed ID: 29129391
[TBL] [Abstract][Full Text] [Related]
19. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital.
van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
